Funding supports phase 2 study of NeuroRestore ACD856 in patients
Company highlights safety and target engagement results for VNA-318 at CTAD meeting
Millions face Medicare decisions each year, but many don’t take advantage of tools that can save them money […]
Updated Date: Fri, 21 Nov 2025 00:00:00 EST
A major review across 73 countries finds that access to antiseizure medications is rising, but safe prescribing isn’t […]
Updated Date: Wed, 19 Nov 2025 00:00:00 EST
Updated Date: Wed, 19 Nov 2025 00:00:00 EST
Updated Date: Wed, 19 Nov 2025 00:00:00 EST
Bimekizumab offers fresh option for patients with chronic conditions
